The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Inverse, protean, and ligand‐selective agonism: matters of receptor conformation
Abstract
Concepts regarding the mechanisms by which drugs activate receptors to produce physiological response have progressed beyond considering the re¬ceptor as a simple on‐off switch. Current evidence suggests that the idea that agonists produce only vary¬ing degrees of receptor activation is obsolete and must be reconciled with data to show that agonist efficacy has texture as well as magnitude. Thus, agonists can block system constitutive response (inverse agonists), behave as positive and inverse agonists on the same receptor (protean agonists), and differ in the stimulus pattern they produce in physiological systems (ligand‐selective agonists). The molecular mechanism for this seemingly diverse array of activities is the same, namely, the selective microaffinity of ligands for different conformational states of the receptor. This paper reviews evidence for the existence of the various types of agonism and the potential therapeutic utility of differ¬ent agonist types.—Kenakin, T. Inverse, protean, and ligand‐selective agonism: matters of receptor confor¬mation. FASEB J. 15, 598‐611 (2001)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Energy Landscapes and Motions of Proteins
Frauenfelder, H., Sligar, S. G., & Wolynes, P. G. (1991) · Science · doi:10.1126/science.1749933 · Cited by 3,250
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., & Foord, S. M. (1998) · Nature · doi:10.1038/30666 · Cited by 2,134
MODEL SYSTEMS FOR THE STUDY OF SEVEN-TRANSMEMBRANE-SEGMENT RECEPTORS
Dohlman, H. G., Thorner, J., Caron, M. G., & Lefkowitz, R. J. (1991) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.60.070191.003253 · Cited by 1,379
Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer
Cuttitta, F., Carney, D. N., Mulshine, J., Moody, T. W., Fedorko, J., Fischler, A., & Minna, J. D. (1985) · Nature · doi:10.1038/316823a0 · Cited by 1,349
Samama, P., Cotecchia, S., Costa, T., & Lefkowitz, R. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53442-6 · Cited by 1,257
GABAB-receptor subtypes assemble into functional heteromeric complexes
Kaupmann, K., Malitschek, B., Schuler, V., Heid, J., Froestl, W., Beck, P., Mosbacher, J., Bischoff, S., Kulik, A., Shigemoto, R., et al. (1998) · Nature · doi:10.1038/25360 · Cited by 1,195
Heterodimerization is required for the formation of a functional GABAB receptor
White, J. H., Wise, A., Main, M. J., Green, A., Fraser, N. J., Disney, G. H., Barnes, A. A., Emson, P., Foord, S. M., & Marshall, F. H. (1998) · Nature · doi:10.1038/25354 · Cited by 1,182
Differential signal transduction by five splice variants of the PACAP receptor
Spongier, D., Waeber, C., Pantaloni, C., Holsboer, F., Bockaert, J., Seeburgt, P. H., & Journot, L. (1993) · Nature · doi:10.1038/365170a0 · Cited by 1,182
GABAB receptors function as a heteromeric assembly of the subunits GABABR1 and GABABR2
Jones, K. A., Borowsky, B., Tamm, J. A., Craig, D. A., Durkin, M. M., Dai, M., Yao, W.-J., Johnson, M., Gunwaldsen, C., Huang, L.-Y., et al. (1998) · Nature · doi:10.1038/25348 · Cited by 1,079
STRUCTURE AND FUNCTION OF G PROTEIN-COUPLED RECEPTORS
Strader, C. D., Fong, T. M., Tota, M. R., Underwood, D., & Dixon, R. A. F. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.000533 · Cited by 1,079
Two G Protein Oncogenes in Human Endocrine Tumors
Lyons, J., Landis, C. A., Harsh, G., Vallar, L., Grünewald, K., Feichtinger, H., Duh, Q.-Y., Clark, O. H., Kawasaki, E., Bourne, H. R., et al. (1990) · Science · doi:10.1126/science.2116665 · Cited by 1,037
Conformational Substates in Proteins
Frauenfelder, H., Parak, F., & Young, R. D. (1988) · Annual Review of Biophysics and Biophysical Chemistry · doi:10.1146/annurev.bb.17.060188.002315 · Cited by 993
Hebert, T. E., Moffett, S., Morello, J.-P., Loisel, T. P., Bichet, D. G., Barret, C., & Bouvier, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.27.16384 · Cited by 775
Arvanitakis, L., Geras-Raaka, E., Varma, A., Gershengorn, M. C., & Cesarman, E. (1997) · Nature · doi:10.1038/385347a0 · Cited by 670
Agonist-receptor efficacy II: agonist trafficking of receptor signals
Kenakin, T. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)89032-x · Cited by 657
Self-citationLOCALISATION OF ENDOCRINE-RELATED TUMOURS WITH RADIOIODINATED ANALOGUE OF SOMATOSTATIN
Krenning, E. P., Breeman, W. A. P., Kooij, P. P. M., Lameris, J. S., Bakker, W. H., Koper, J. W., Ausema, L., Reubi, J. C., & Lamberts, S. W. J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91258-0 · Cited by 625
Potent Inhibition of HIV-1 Infectivity in Macrophages and Lymphocytes by a Novel CCR5 Antagonist
Simmons, G., Clapham, P. R., Picard, L., Offord, R. E., Rosenkilde, M. M., Schwartz, T. W., Buser, R., Wells, T. N. C., & Proudfoot, A. E. I. (1997) · Science · doi:10.1126/science.276.5310.276 · Cited by 608
Kjelsberg, M. A., Cotecchia, S., Ostrowski, J., Caron, M. G., & Lefkowitz, R. J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45962-5 · Cited by 589
Hall, R. A., Premont, R. T., Chow, C.-W., Blitzer, J. T., Pitcher, J. A., Claing, A., Stoffel, R. H., Barak, L. S., Shenolikar, S., Weinman, E. J., et al. (1998) · Nature · doi:10.1038/33458 · Cited by 585
Morphine Activates Opioid Receptors without Causing Their Rapid Internalization
Keith, D. E., Murray, S. R., Zaki, P. A., Chu, P. C., Lissin, D. V., Kang, L., Evans, C. J., & von Zastrow, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19021 · Cited by 552
Amara, A., Gall, S. L., Schwartz, O., Salamero, J., Montes, M., Loetscher, P., Baggiolini, M., Virelizier, J.-L., & Arenzana-Seisdedos, F. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.1.139 · Cited by 552
Interaction of Convulsive Ligands with Benzodiazepine Receptors
Braestrup, C., Schmiechen, R., Neef, G., Nielsen, M., & Petersen, E. N. (1982) · Science · doi:10.1126/science.6281892 · Cited by 547
Costa, T., & Herz, A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7321 · Cited by 536
Metabotropic Glutamate Receptor 5 Is a Disulfide-linked Dimer
Romano, C., Yang, W.-L., & O'Malley, K. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.45.28612 · Cited by 536
Somatostatin-Receptor Imaging in the Localization of Endocrine Tumors
Lamberts, S. W. J., Barker, W. H., Reubi, J.-C., & Krenning, E. P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011013231805 · Cited by 532
Constitutively active mutants of rhodopsin
Robinson, P. R., Cohen, G. B., Zhukovsky, E. A., & Oprian, D. D. (1992) · Neuron · doi:10.1016/0896-6273(92)90034-b · Cited by 512
Berg, K. A., Maayani, S., Goldfarb, J., Scaramellini, C., Leff, P., & Clarke, W. P. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.1.94 · Cited by 510
Christopoulos, G., Perry, K. J., Morfis, M., Tilakaratne, N., Gao, Y., Fraser, N. J., Main, M. J., Foord, S. M., & Sexton, P. M. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.1.235 · Cited by 486
Dimerization of the δ Opioid Receptor:
Cvejic, S., & Devi, L. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.43.26959 · Cited by 484
Mack, M., Luckow, B., Nelson, P. J., Cihak, J., Simmons, G., Clapham, P. R., Signoret, N., Marsh, M., Stangassinger, M., Borlat, F., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.8.1215 · Cited by 405
Bai, M., Trivedi, S., & Brown, E. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.36.23605 · Cited by 402
Signoret, N., Oldridge, J., Pelchen-Matthews, A., Klasse, P. J., Tran, T., Brass, L. F., Rosenkilde, M. M., Schwartz, T. W., Holmes, W., Dallas, W., et al. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.3.651 · Cited by 375
Inverse agonist activity of beta-adrenergic antagonists.
Chidiac, P., Hebert, T. E., Valiquette, M., Dennis, M., & Bouvier, M. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10022-9 · Cited by 372
Three cytoplasmic loops of rhodopsin interact with transducin.
König, B., Arendt, A., McDowell, J. H., Kahlert, M., Hargrave, P. A., & Hofmann, K. P. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.18.6878 · Cited by 371
Allen, L. F., Lefkowitz, R. J., Caron, M. G., & Cotecchia, S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11354 · Cited by 322
Pincus, D. W., DiCicco-Bloom, E. M., & Black, I. B. (1990) · Nature · doi:10.1038/343564a0 · Cited by 315
Fluorescent Labeling of Purified β2 Adrenergic Receptor
Gether, U., Lin, S., & Kobilka, B. K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.47.28268 · Cited by 278
Virgolini, I., Raderer, M., Kurtaran, A., Angelberger, P., Banyai, S., Yang, Q., Li, S., Banyai, M., Pidlich, J., Niederle, B., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199410273311703 · Cited by 257
Robb, S., Cheek, T. R., Hannan, F. L., Hall, L. M., Midgley, J. M., & Evans, P. D. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06385.x · Cited by 248
Smit, M. J., Leurs, R., Alewijnse, A. E., Blauw, J., Van Nieuw Amerongen, G. P., Van De Vrede, Y., Roovers, E., & Timmerman, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6802 · Cited by 242
Kuhmann, S. E., Platt, E. J., Kozak, S. L., & Kabat, D. (2000) · Journal of Virology · doi:10.1128/jvi.74.15.7005-7015.2000 · Cited by 223
Bonhaus, D. W., Chang, L. K., Kwan, J., & Martin, G. R. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37876-0 · Cited by 223
μ Opioid Receptor Phosphorylation, Desensitization, and Ligand Efficacy
Yu, Y., Zhang, L., Yin, X., Sun, H., Uhl, G. R., & Wang, J. B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.46.28869 · Cited by 219
The Cubic Ternary Complex Receptor-Occupancy Model III. Resurrecting Efficacy
Weiss, J. M., Morgan, P. H., Lutz, M. W., & Kenakin, T. P. (1996) · Journal of Theoretical Biology · doi:10.1006/jtbi.1996.0139 · Cited by 212
Self-citationDefects in G Protein-Coupled Signal Transduction in Human Disease
Spiegel, A. M. (1996) · Annual Review of Physiology · doi:10.1146/annurev.ph.58.030196.001043 · Cited by 199
De Ligt, R. A. F., Kourounakis, A. P., & IJzerman, A. P. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703311 · Cited by 190
Cloning and characterization of MUPP1, a novel PDZ domain protein
Ullmer, C., Schmuck, K., Figge, A., & Lübbert, H. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00141-0 · Cited by 189
Ward, D. T., Brown, E. M., & Harris, H. W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14476 · Cited by 187
Bai, M., Trivedi, S., Kifor, O., Quinn, S. J., & Brown, E. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.2834 · Cited by 183
Agonist-receptor efficacy I: mechanisms of efficacy and receptor promiscuity
Kenakin, T. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)89020-3 · Cited by 176
Self-citationHaegerstrand, A., Jonzon, B., Dalsgaard, C. J., & Nilsson, J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.15.5993 · Cited by 169
Fraser, N. J., Wise, A., Brown, J., McLatchie, L. M., Main, M. J., & Foord, S. M. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23257-0 · Cited by 169
Kroog, G. S., Jensen, R. T., & Battey, J. F. (1995) · Medicinal Research Reviews · doi:10.1002/med.2610150502 · Cited by 166
Tian, W. N., Duzic, E., Lanier, S. M., & Deth, R. C. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10026-6 · Cited by 161
RAMPs: accessory proteins for seven transmembrane domain receptors
Foord, S. M., & Marshall, F. H. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01347-4 · Cited by 151
Gozes, I., McCune, S., Jacobson, L., Warren, D., Moody, T. W., Fridkin, M., & Brenneman, D. E. (1991) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24703-6 · Cited by 147
Cloning and expression of the human vasoactive intestinal peptide receptor.
Sreedharan, S. P., Robichon, A., Peterson, K. E., & Goetzl, E. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4986 · Cited by 145
Kovoor, A., Nappey, V., Kieffer, B. L., & Chavkin, C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.44.27605 · Cited by 136
Porter, J. E., Hwa, J., & Perez, D. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.45.28318 · Cited by 132
Differential Opioid Agonist Regulation of the Mouse μ Opioid Receptor
Blake, A. D., Bot, G., Freeman, J., & Reisine, T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.2.782 · Cited by 131
Is there a ‘lock’ for all agonist ‘keys’ in 7TM receptors?
Schwartz, T. W., & ROSENKILDE, M. M. (1996) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(96)10017-1 · Cited by 130
Expanding horizons for receptors coupled to G proteins: diversity and disease
Coughlin, S. R. (1994) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(94)90135-x · Cited by 127
A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth.
Moody, T. W., Zia, F. Z., Draoui, M., Brenneman, D. E., Fridkin, M., Davidson, A., & Gozes, I. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.10.4345 · Cited by 126
工藤, 正., Osuga, Y., Kobilka, B. K., & Hsueh, A. J. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.37.22470 · Cited by 117
Abnormalities in G protein-coupled signal transduction pathways in human disease.
Am, S., Weinstein, L. S., & Shenker, A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116680 · Cited by 117
Rodrı́guez-Frade, J. M., Vila‐Coro, A. J., Martín, A., Nieto, M., Sánchez‐Madrid, F., Proudfoot, A. E. I., Wells, T. N. C., Martínez‐A, C., & Mellado, M. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.144.4.755 · Cited by 113
Use of Constitutive G Protein-Coupled Receptor Activity for Drug Discovery
Chen, G., Way, J. M., Armour, S. L., Watson, C., Queen, K., Jayawickreme, C. K., Chen, W. J., & Kenakin, T. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26450-6 · Cited by 111
Self-citationSeifert, R., Gether, U., Wenzel‐Seifert, K., & Kobilka, B. K. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.2.348 · Cited by 110
Schols, D., Esté, J. A., Cabrera, C., & Clercq, E. D. (1998) · Journal of Virology · doi:10.1128/jvi.72.5.4032-4037.1998 · Cited by 109
Law, P., Erickson, L. J., Kouhen, R. E., Dicker, L. H., Solberg, J. C., Wang, W., Miller, E., Burd, A. L., & Loh, H. H. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12075-5 · Cited by 109
Specificity of receptor-G protein interactions: Searching for the structure behind the signal
Hedin, K. E., Duerson, K. C., & Clapham, D. E. (1993) · Cellular Signalling · doi:10.1016/0898-6568(93)90046-o · Cited by 106
Watson, C., Chen, G., Irving, P. E., Way, J. M., Chen, W.-J., & Kenakin, T. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.6.1230 · Cited by 103
Self-citationMukhopadhyay, S., McIntosh, H. H., Houston, D. B., & Howlett, A. C. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26454-3 · Cited by 101
Novel Actions of Inverse Agonists on 5-HT2C Receptor Systems
Berg, K. A., Stout, B. D., Cropper, J. D., Maayani, S., & Clarke, W. P. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23183-7 · Cited by 100
Armour, S. L., Foord, S., Kenakin, T., & Chen, W.-J. (1999) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00074-5 · Cited by 96
Self-citationViral quasispecies and the problem of vaccine-escape and drug-resistant mutants
Domingo, E., Menéndez‐Arias, L., Quiñones‐Mateu, M. E., Holguín, Á., Gutiérrez‐Rivas, M., Martínez, M. Á., Quer, J., Novella, I. S., & Holland, J. J. (1997) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8861-5_4 · Cited by 95
Agonist-induced modulation of inverse agonist efficacy at the beta 2-adrenergic receptor.
Chidiac, P., Nouet, S., & Bouvier, M. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09338-1 · Cited by 93
Wiens, B. L., Nelson, C. S., & Neve, K. A. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.2.435 · Cited by 93
Münch, G. W., Dees, C., Hekman, M., & Palm, D. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb16023.x · Cited by 92
Weinstein, L. S., Gejman, P. V., de Mazancourt, P., et al. (1992) · Genomics · doi:10.1016/0888-7543(92)90056-x · Cited by 92
Agonist-specific receptor conformations
Kenakin, T. P. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)01127-9 · Cited by 88
Self-citationLigand-Induced Phosphorylation, Clustering, and Desensitization of A1 Adenosine Receptors
Ciruela, F., Saura, C. A., Canela, E. I., Mallol, J., Lluís, C., & Franco, R. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.5.788 · Cited by 85
Inverse Agonism and Neutral Antagonism at α1a- and α1b-Adrenergic Receptor Subtypes
Rossier, O., Abuin, L., Fanelli, F., Leonardi, A., & Cotecchia, S. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.5.858 · Cited by 84
The turning wheel: a study in steady states.
Wyman, J. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.10.3983 · Cited by 82
Clifford, E. E., Martin, K. A., Dalal, P., Thomas, R., & Dubyak, G. (1997) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1997.273.3.c973 · Cited by 77
Rebound intragastric hyperacidity after abrupt withdrawal of histamine H2 receptor blockade.
Nwokolo, C. U., Smith, J., Sawyerr, A. M., & Pounder, R. E. (1991) · Gut · doi:10.1136/gut.32.12.1455 · Cited by 71
Westphal, R. S., Backstrom, J. R., & Sanders‐Bush, E. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10237-x · Cited by 70
Ikezu, T., Okamoto, T., Ogata, E., & Nishimoto, I. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)81359-t · Cited by 69
ROSENKILDE, M. M., & Schwartz, T. W. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26427-0 · Cited by 69
Wade, S. M., Lim, W. K., Lan, K.-L., et al. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.5.1005 · Cited by 68
Pharmacology of a constitutively active muscarinic receptor generated by random mutagenesis.
Spalding, T. A., Burstein, E. S., Bräuner‐Osborne, H., et al. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12181-2 · Cited by 65
The Stability of the Agonist β2-Adrenergic Receptor-Gs Complex: Evidence for Agonist-Specific States
Krumins, A. M., & Barber, R. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.1.144 · Cited by 64
The mitogenic effects of vasoactive neuropeptides on cultured smooth muscle cell lines
Mitsuhashi, M., & Payan, D. G. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90034-8 · Cited by 58
Selection of distinct conformational states of the 5‐HT3receptor by full and partial agonists
van Hooft, J. A., & Vijverberg, H. P. M. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15269.x · Cited by 54
Efficacy in drug receptor theory: outdated concept or under-valued tool?
Kenakin, T. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01361-9 · Cited by 51
Self-citationHistamine H2-Receptor Antagonists in Peptic Ulcer Disease: Efficacy in Healing Peptic Ulcers
Deakin, M., & Williams, J. G. (1992) · Drugs · doi:10.2165/00003495-199244050-00003 · Cited by 47
Signal transduction by calcitonin
Horne, W. C., Shyu, J., Chakraborty, M., & Baron, R. (1994) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(95)92521-j · Cited by 44
Meller, E., Puza, T., Diamond, J., Lieu, H. D., & Bohmaker, K. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10372-8 · Cited by 35
Donaldson, L. F., Hanley, M. R., & Villablanca, A. C. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)01048-1 · Cited by 25
Vasoactive intestinal peptide stimulates protein phosphorylation in a colonic epithelial cell line
Cohn, J. A. (1987) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1987.253.3.g420 · Cited by 24
Cited by
Nichols, D. E., & Nichols, C. D. (2008) · Chemical Reviews · doi:10.1021/cr078224o · Cited by 895
Synthetic Multivalent Ligands as Probes of Signal Transduction
Kiessling, L. L., Gestwicki, J. E., & Strong, L. E. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200502794 · Cited by 864
Wei, H., Ahn, S., Shenoy, S. K., Karnik, S. S., Hunyady, L., Luttrell, L. M., & Lefkowitz, R. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834556100 · Cited by 690
GRKs and β-arrestins: roles in receptor silencing, trafficking and signaling
Reiter, E., & Lefkowitz, R. J. (2006) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2006.03.008 · Cited by 666
Allosteric binding sites on cell-surface receptors: novel targets for drug discovery
Christopoulos, A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd746 · Cited by 664
Metadata
- Authors
- KENAKIN, T.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2001-03
- Volume
- 15
- Issue
- 3
- Pages
- 598-611
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2087135060
- Cited by
- 408
- References
- 100
- FWCI
- 8.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.